Publisher name UC San Diego Today Researchers report the development of a next-generation genetic platform designed to selectively target and counter antibiotic-resistant bacteria. The approach leverages programmable genetic tools to disrupt resistance mechanisms, contributing to broader efforts to address the global rise of antimicrobial resistance through precision biotechnology strategies. 👉 Read the full article: Next-generation genetics technology developed to counter t

Publisher name GEN – Genetic Engineering & Biotechnology News The article reports preclinical findings showing that stem cell–derived neurons can migrate toward injury sites in the brain and form functional connections with host neural circuits. The results contribute to ongoing translational research efforts aimed at improving cell-based strategies for neurological repair while highlighting remaining challenges in safety, control, and long-term integration. 👉 Read the full

Publisher name Alliance for Regenerative Medicine The post highlights individual patient experiences to illustrate the clinical impact and increasing maturity of cell and gene therapies, including bespoke gene therapy and CAR-T applications. These examples are presented as indicators of a sector moving toward more disciplined development, sustainable growth, and broader real-world relevance beyond experimental settings. 👉 Read the full article: Patient stories that illustrat

Publisher name University of British Columbia Faculty of Medicine The article reports on new stem cell engineering research that enables more precise control over cell behavior, durability, and function after transplantation. These advances are positioned as foundational for developing living drugs that can respond dynamically within the body, with potential implications for cell therapies beyond current autologous and static treatment models. 👉 Read the full article: Stem c

The discussion focuses on how an Italian nonprofit organization navigated scientific development, manufacturing readiness, and regulatory engagement to achieve U.S. Food and Drug Administration approval for a gene therapy. It reflects broader questions about alternative development models beyond traditional commercial biotech and how regulatory frameworks can accommodate nonprofit-led innovation in rare diseases. 👉 View the full video: EP 29 - How an Italian Non Profit Got a

Publisher name Pharmaceutical Technology The commentary discusses systemic pressures facing the regenerative medicine sector beyond scientific development, including fragile business models, reimbursement uncertainty, and limited manufacturing scalability. It argues that without coordinated policy, financing, and infrastructure solutions, many advanced therapies may struggle to transition from clinical promise to sustainable real-world availability. 👉 Read the full article:

Publisher name CBS News, 60 Minutes The article examines how approved genetic therapies can offer curative outcomes for rare and severe diseases while carrying price tags that reach several million dollars per dose. It highlights the structural drivers behind these costs, including complex manufacturing, small patient populations, and reimbursement challenges, raising questions about long-term sustainability and equitable access within healthcare systems. 👉 Read the full art

Publisher name World Economic Forum Global investment in regenerative medicine infrastructure is increasingly framed as an economic and health system priority rather than a niche scientific endeavor. The article highlights how manufacturing capacity, skilled workforce development, regulatory readiness, and cross-border coordination are now critical bottlenecks for scaling cell and gene therapies worldwide. It positions infrastructure planning as essential to ensuring equitabl

Published on: University of Colorado Boulder Scientists have found that manipulating cellular storage hubs called P bodies can rewind mature cells to a more flexible state and push them toward hard-to-generate lineages such as germ-cell-like or totipotent-like cells. The study shows how releasing specific RNAs from these structures reshapes cell identity, opening new possibilities for fertility treatment, organ regeneration, and early-stage disease modeling. 👉 Read the full

Published on University of Colorado Boulder CU Boulder scientists have discovered that P bodies act as organized RNA storage hubs that steer how stem cells decide their identity. By unlocking these structures, researchers were able to revert mature cells to earlier developmental states and generate germ-cell-like and totipotent-like cells with high efficiency. 👉 Read the full article: Scientists Discover New Way to Shape What a Stem Cell Becomes Disclaimer Images used are fo

Published on Bloomberg A new Bloomberg feature examines how experimental low-cost cancer treatments are reshaping debates around drug...

Published on Phys.org Researchers are developing strategies to improve the safety of stem cell therapies, focusing on reducing potential...

Published on The Scientist Researchers are advancing patient-derived dendritic cell immunotherapy as a personalized cancer treatment. By...

Published on Stem Cell Research & Therapy A recent study in Stem Cell Research & Therapy explores how bone marrow-derived stem cells...

Published on Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s A-Gene initiative demonstrates how Quality by...

Published on Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s A-Cell initiative showcases how Quality by...

Published in Frontiers in Bioengineering and Biotechnology A new review highlights mitochondria as central regulators of pluripotency,...

Published in International Journal of Impotence Research A new commentary outlines how low-intensity shockwave therapy and platelet-rich...

Published in Stem Cells Translational Medicine (Oxford Academic) A large open-access study reports long-term safety and functional gains...

Published in Radiology (RSNA) A new editorial highlights the promise of CRISPR-based triple-modality imaging for tracking stem cell...